LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. (“Savara ” or “the Company”) (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Savara Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – SVRA
Tag: Financial Results
Fly-E Group, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – FLYE
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Fly-E Group, Inc. (“Fly-E ” or “the Company”) (NASDAQ: FLYE ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.… Continue reading Fly-E Group, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – FLYE
PureHealth Delivers Strong 9-Month Results with AED 20.1 Billion in Revenue and AED 1.55 Billion in Net Profit
ABU DHABI, UAE, Nov. 3, 2025 /PRNewswire/ — PureHealth Holding PJSC (“PureHealth” or “the Group”) (ADX: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the nine-month period ended 30 September 2025. The Group reported revenue of AED 20.1 billion, up 6% year-on-year, reflecting strong performance across both its… Continue reading PureHealth Delivers Strong 9-Month Results with AED 20.1 Billion in Revenue and AED 1.55 Billion in Net Profit
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. (“Savara” or “the Company”) (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.… Continue reading SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange… Continue reading LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
FLYE Investors Have Opportunity to Lead Fly-E Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fly-E Group, Inc. (“Fly-E” or “the Company”) (NASDAQ: FLYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and… Continue reading FLYE Investors Have Opportunity to Lead Fly-E Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX
bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion
bp divests non-controlling interests in Permian and Eagle Ford midstream assets to private investor Sixth Street for $1.5 billion Agreement enables bp to unlock capital from infrastructure, while retaining operatorship and control of strategic midstream assets Transaction delivers a material contribution towards bp’s 2025 expected divestment proceeds and target of $20 billion of divestments by the end… Continue reading bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer’s disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK, Iceland, Nov. 3, 2025 /PRNewswire/ — Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced… Continue reading Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer’s disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK, Iceland, Nov. 3, 2025 /PRNewswire/ — Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced… Continue reading Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease